文献速递神经MR

肌萎缩侧索硬化中的脊髓灰质萎缩

Spinal Cord Gray Matter Atrophy in Amyotrophic Lateral Sclerosis.
PubMed 文献 · AJNR Am J Neuroradiol · 2017-11-09

研究纳入29例肌萎缩侧索硬化患者与22例健康对照,采用3T MR成像自动测量脊髓、灰质和白质横截面积,评估其与基线及1年后临床残疾的关联。灰质萎缩区分患者与对照的敏感度高于脊髓萎缩(P=.004 vs P=.02),灰质与白质横截面积联合可改善1年后临床评分的预测(R²=0.74 vs 0.54)。

要点

  • 灰质横截面积萎缩区分肌萎缩侧索硬化患者与对照的P=.004,优于脊髓萎缩的P=.02。
  • 灰质与脊髓横截面积均与基线临床评分相关(R=0.56与R=0.55,P<.01)。
  • 灰质与白质横截面积联合预测1年后临床评分R²=0.74,优于单用临床评分的R²=0.54。

核心结论

  • 尽管相比脊髓横截面积的改善幅度不大,本研究提示灰质横截面积有潜力作为MR成像结构生物标志物来监测肌萎缩侧索硬化的演变。

研究设计与样本

  • 研究纳入29例肌萎缩侧索硬化患者和22例健康对照,采用3T MR成像扫描,自动处理MR数据测量脊髓、灰质和白质横截面积,并在MR成像时及1年后记录标准功能量表评分。

关键影像表现/征象

  • 灰质萎缩区分肌萎缩侧索硬化患者与对照的P=.004,脊髓萎缩的P=.02。
  • 灰质与脊髓横截面积均与基线临床评分呈良好相关(灰质R=0.56,脊髓R=0.55;P<.01)。

诊断标准与关键数值

  • 灰质横截面积萎缩区分肌萎缩侧索硬化患者与对照的P=.004,脊髓横截面积萎缩的P=.02。
  • 灰质与脊髓横截面积与基线临床评分相关:灰质R=0.56,脊髓R=0.55(P<.01)。
  • 预测1年后临床评分:单用临床评分R²=0.54,联合灰质与白质横截面积后R²=0.74。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: There is an emerging need for biomarkers to better categorize clinical phenotypes and predict progression in amyotrophic lateral sclerosis. This study aimed to quantify cervical spinal gray matter atrophy in amyotrophic lateral sclerosis and investigate its association with clinical disability at baseline and after 1 year.

MATERIALS AND METHODS: Twenty-nine patients with amyotrophic lateral sclerosis and 22 healthy controls were scanned with 3T MR imaging. Standard functional scale was recorded at the time of MR imaging and after 1 year. MR imaging data were processed automatically to measure the spinal cord, gray matter, and white matter cross-sectional areas. A statistical analysis assessed the difference in cross-sectional areas between patients with amyotrophic lateral sclerosis and controls, correlations between spinal cord and gray matter atrophy to clinical disability at baseline and at 1 year, and prediction of clinical disability at 1 year.

RESULTS: Gray matter atrophy was more sensitive to discriminate patients with amyotrophic lateral sclerosis from controls (P = .004) compared with spinal cord atrophy (P = .02). Gray matter and spinal cord cross-sectional areas showed good correlations with clinical scores at baseline (R = 0.56 for gray matter and R = 0.55 for spinal cord; P < .01). Prediction at 1 year with clinical scores (R2 = 0.54) was improved when including a combination of gray matter and white matter cross-sectional areas (R2 = 0.74).

CONCLUSIONS: Although improvements over spinal cord cross-sectional areas were modest, this study suggests the potential use of gray matter cross-sectional areas as an MR imaging structural biomarker to monitor the evolution of amyotrophic lateral sclerosis.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Paquin MÊ, El Mendili MM, Gros C, et al. Spinal Cord Gray Matter Atrophy in Amyotrophic Lateral Sclerosis. AJNR Am J Neuroradiol. 2017. PMID: 29122760. doi:10.3174/ajnr.A5427

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。